Envue Medical Inc.
13F holders, Q4 2025 (December 31)6holders
1new positions
1sold out
1famous investor
$2.31avg. 13F price*
At the end of Q4 2025, 6 institutions reported holding Envue Medical Inc. in their 13F filings, unchanged from Q3 2025. 1 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($38K), Tower Research Capital LLC (TRC) ($4K) and UBS Group AG ($139). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Envue Medical Inc.
- CUSIP
- 63008J884
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $38K |
| Exits | 1 | $6K |
All 13F filers, Q3 2025 → Q4 2025: 17,721 shares bought and 1,000 shares sold, net +16,721 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Citadel Advisors | 0.00% | New | 16,516 | $38K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +187.9% | 1,805 | $4K |
| UBS Group AG | 0.00% | Add +71.4% | 60 | $139 |
| SBI Securities Co., Ltd. | 0.00% | No change | 15 | $35 |
| Bank of America Corp. | 0.00% | Add +33.3% | 8 | $18 |
| Citigroup Inc. | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is ENVUE MEDICAL INC.'s weight in each manager's 13F, not the share of Envue Medical Inc. the manager owns.